The regulatory effect of AVP on the hypothalamic-pituitary-adrenal (HPA) axis suggests that AVP receptor (AVPR) modulators could be used to treat various central nervous system disorders, including depression, anxiety, and post-traumatic stress disorder (Ryckmans 2010). This evidence concerns the gene AVP and depressive disorder.